Effect of Lactoferrin on the Phagocytic Activity of Polymorphonuclear Leucocytes Isolated from Blood of Patients with Autoimmune Diseases and Staphylococcus aureus Allergy

  • Vladi Manev
  • Ana Maneva
  • Ljuben Sirakov
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 443)

Summary

Phagocytic number (PN) and phagocytic index (PI) of neutrophils isolated from blood of patients with autoimmune diseases, allergy to Staphylococcus aureus and from blood of healthy individuals were examined. Our results concerning the influence of lactoferrin (Lf); (6.7 mg/1) on the PI of PMN showed that: 1) Lf enhances reliable PI of PMN at the 30-th minute starting the phagocytic reaction in patients with autoimmune disease in an active stage, in blood donors treated as healthy with the presence of autoantibodies, in patients with autoimmune diseases and proved autoantibodies against tissue, cell antigens and collagen, 2) Lf influences non-significantly PI of PMN in patients with autoimmune collagen diseases in remission, 3) Lf increases PI of PMN with 19% only in 58% from the assessed patients with Staphylococcus aureus, and 4) Lf decreases non-significantly PI of PMN in the healthy controls. Our studies on the effect of Lf on the phagocytic activity of PMN suggest that Lf has stronger effect on the PN compared to the PI: 1) Lf enhances with 86% the PN in patients with Staphylococcus aureus, 2) Lf increases PN of PMN in all of the assessed patients with autoimmune collagen diseases in active stage (mean with 72%), and 3) Lf increases PN of PMN in 4 from the 5 investigated healthy controls (mean with 22%). Our results show a “corrective” effect of Lf on the phagocytic functions in the investigated groups of patients. The possible mechanisms, by which Lf increases PN and PI of neutrophils, is discussed: 1) they may concern the antioxidative properties of Lf to block the iron ions in their catalytic inactive form or to take part as ferric-Lf in an oxidative-reduction processes on the plasma membrane and controlling transmembrane transport systems, 2) Lf decreases the negative surface charge and thus enhances the adherent ability of the PMN. Probably to this stimulated adherent ability dues the increased ingestion of bacteria in the presence of Lf, and 3) The “changed” membrane of PMN may have higher number receptors for Lf to bind more molecules of exogenous Lf. The increase of Lf binding which enhances the adherence and aggregation of neutrophils, facilitates the phagocytosis.

Keywords

Rheumatoid Arthritis Systemic Lupus Erythematosus Phagocytic Activity Active Stage Phagocytic Function 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adamik B., Wlaszczyk A., 1996, 50 (1) 33–41.Google Scholar
  2. 2.
    Aguas AP., Esaguy N., Sunkel CE., Silva MT., Infect. Immun., 1990, 58 (5) 1461–1470.PubMedGoogle Scholar
  3. 3.
    Al-Hadithy H., Isenberg DA., Addison IE., Glodstone AH., Snaith ML., Ann. Rheum. Dis., 1981, 43, 33–36.Google Scholar
  4. 4.
    Aruoma 01., Halliwell B., Biochem. J., 1987, 241, 273–278.Google Scholar
  5. 5.
    Asako H, Kurose I., Wolf RE, Granger DN., Microcirculation, 1994, 1 (1) 27–34.PubMedCrossRefGoogle Scholar
  6. 6.
    Attia WM., Shams AH., Ali MKH., Clark HW., Brown T., Bellanti JA., Ann. Allergy,l982, 48, 279–282.Google Scholar
  7. 7.
    Baynes RD., Bezwoda WR., Adv. Exp.Med. Biol., 1994, 357, 133–141.PubMedCrossRefGoogle Scholar
  8. 8.
    Bennett RM., Quartey EAC., Holt PJL., Arthritis Rheum., 1973, 16, 186–190.PubMedCrossRefGoogle Scholar
  9. 9.
    Boghossian SH., Isenberg DA., Wright G. et al., Ann. Rheum. Dis., 1984, 43 (4) 541–550.PubMedCrossRefGoogle Scholar
  10. 10.
    Boxer LA., Coates TD., Haak RA., Wolach JB., Hoffstein S., Baehner RL. The New Engl. J. Med., 1982, 12, 404–410.Google Scholar
  11. 11.
    Boxer LA., Haak RA., Yang HH., Wolach JB., Whitcomb JA., Butterick CJ., Baehner RL. J. Clin. Invest., 1982, 70, 1049–1057.CrossRefGoogle Scholar
  12. 12.
    Brandt L., Hedberg H., Scand. J. Haematol., 1969, 6, 348–353.PubMedCrossRefGoogle Scholar
  13. 13.
    Breton-Gorius J., Mason D., Buriot D., Vlide J., Griscelli C., AM. J. Pathol., 1980, 99, 413–419.PubMedGoogle Scholar
  14. 14.
    Briggs RC., Glass WF., Montiel MM., Hnilica LS., J. Histochem. Cytochem., 1981, 10, 1128–1136.CrossRefGoogle Scholar
  15. 15.
    Britigan BE., Hassett DJ., Rosen GM., Hammill DR., Cohen MS., Biochem. J., 1989, 264, 447–455.PubMedGoogle Scholar
  16. 16.
    Britigan BE., Serody JS., Cohen MS., Adv. Exp. Med. Biol., 1994, 357, 143–156.PubMedCrossRefGoogle Scholar
  17. 17.
    Brock J., Immunol. Today, 1995, 16 (9), 417–419.PubMedCrossRefGoogle Scholar
  18. 18.
    Bullen JJ., Armstrong JA., Immunol., 1979, 36, 781–791.Google Scholar
  19. 19.
    Butler JE., Biochim. Biophys. Acta., 1973, 29, 341–346.Google Scholar
  20. 20.
    Cohen MS., Mao J., Rasmussen GT., Serody JS., Britigan BE., J. Infect. Dis., 1992, 166, 1375–1378.PubMedCrossRefGoogle Scholar
  21. 21.
    Esaguy N., Freire 0., van-Embden JD., Aguas AR, Scand. J. Immunol., 1993, 38 (2) 147–152.Google Scholar
  22. 22.
    Faucheux BA., Nillesse N., Damier P., Spik G.,Mouatt-Prigent A., Pierce A., Leveugle B., Kuhis N., Hauw JJ., Agid Y., Proc. Natl. Acad. Sci. USA, 1995, 92 (21) 9603–9607.CrossRefGoogle Scholar
  23. 23.
    Fields T.. Gerardy EN., Ghebrehwet B., Bennett RS., Lawley TJ., Hall RR, Plotz PH., Karsh JR., Frank MM., Hamburger MI., J. Rheumatol., 1983, 10 (4) 550–557.Google Scholar
  24. 24.
    Fleet JC., Nutr. Rev., 1995, 53 (8) 226–227.PubMedCrossRefGoogle Scholar
  25. 25.
    Hakansson L., Venge P., Immunology, 1982, 47, 687–694.PubMedGoogle Scholar
  26. 26.
    Heifets L., Katsuyuki I., Goren MB., J. Reticuloendothel. Soc., 1980, 28, 391–403.Google Scholar
  27. 27.
    Kurose I., Yamada T., Wolf R., Granger DN., J. Leukoc. Biol., 1994, 55 (6) 771–777.PubMedGoogle Scholar
  28. 28.
    Lerche A., Bisgaard H., Christensen JD., Venge R, Dahl R., Sondergaard J., Allergy, 1988, 43, 139–145.PubMedCrossRefGoogle Scholar
  29. 29.
    Lima ME, Kierzenbaum F., J. Immunol., 1985, 134 (6) 4176–4183.PubMedGoogle Scholar
  30. 30.
    Maher RJ., Cao D., Boxer LA., Petty HR., J. Cell Physiol., 156 (2) 226–234.Google Scholar
  31. 31.
    Maneva A., Sirakov LM., Manev V., Int. J. Biochem., 1983, 15, 981–984.PubMedCrossRefGoogle Scholar
  32. 32.
    Masson PL., Heremans JF., Schonne E., J. Exp. Med., 1969, 130, 643–658.PubMedCrossRefGoogle Scholar
  33. 33.
    Mulder AH., Horst G., van Leeuwen MA., Climburg P., Kallenger CG., Arthritis Rheum., 1993, 36 (8) 1054–1060.PubMedCrossRefGoogle Scholar
  34. 34.
    Mulder AH., Horst G., Haagsma EB., Limburg PC., Kleibeuker JH., Kallenger CG., Hepatology, 1993, 17 (3) 411–417.PubMedCrossRefGoogle Scholar
  35. 35.
    Nisimoto Y., Otsuka-Murakami H.,Biochem. Biophys. Acta, 1990, 1040, 260–266.CrossRefGoogle Scholar
  36. 36.
    Okuda K., Okamoto R., Noguchi Y., Tadokoro I., Jpn. J. Exp. Med., 1975, 45, 1–17.PubMedGoogle Scholar
  37. 37.
    Oseas R., Yang HH., Baehner RL., Boxer LA., Blood, 1981, 5, 939–946.Google Scholar
  38. 38.
    Parris TM., Kimberly RP., Inman RD., McDouglas JS., Gibofski A., Christian CL., Ann. Int. Med., 1982, 4, 526–532.Google Scholar
  39. 39.
    Peen E., Sundqvist T., Skogh T., Clin. Exp. Immunol., 1996, 103 (3) 403–407.PubMedCrossRefGoogle Scholar
  40. 40.
    Skogh T., Peen E., Adv. Exp. Med. Biol., 1993, 336, 533–538.PubMedGoogle Scholar
  41. 41.
    Steffen C., Allgem. Experim. Immunol. Immunopathol.. Stuttgard, G. Theime Verlag, 1968.Google Scholar
  42. 42.
    Sun IL., Crane FL., Morre DJ., Low H., Faulk WP., Biochem. Biophys. Res. Commun., 1991, 176 (1) 497–504.CrossRefGoogle Scholar
  43. 43.
    Turner RA., Schumacher HR., Myers AR., J. Clin. Invest., 1973, 5. 1632–1635.CrossRefGoogle Scholar
  44. 44.
    Van Asbeck BS., Marx JJM., Stryvenberg A., van Kats J., Verhoef J., J. Immunol., 1984, 851–856.Google Scholar
  45. 45.
    Wang D., Pabst KM., Aida Y., Pabat MJ., J. Leucocyte Biol., 1995, 57, 865–874.Google Scholar
  46. 46.
    Weissmann G., J. Lab. Clin. Med., 1982, 100 (3), 322–333.Google Scholar
  47. 47.
    Zimecki M., Machniki M.,Arch. Immunol. Ther. Exp., 1994, 42 (3), 171–177.Google Scholar
  48. 48.
    Zimecki M., Wieczorek Z., Mazurier J., Spik G., Arch. Immunol. Ther. Exp., 1995, 43 (3–4), 207–209.Google Scholar
  49. 49.
    Zweiman B., von Allmen C., Moskovitz A., Atkins M., Taylor M., Korchak H., J. Leukoc. Biol., 1993, 53 (6), 727–731.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Vladi Manev
    • 1
  • Ana Maneva
    • 2
  • Ljuben Sirakov
    • 2
  1. 1.Department of Experimental ImmunologyMilitary Medical AcademySofiaBulgaria
  2. 2.Department of BiochemistryMedical Faculty, Medical UniversityBulgaria

Personalised recommendations